| Home > Publications Database > How can Alzheimer's disease blood-based biomarkers reach clinical practice? > Access to Fulltext |
DZNE-2025-01229
|
|||||||
| version 1 |
| ||||||
| Restricted | |||||||
DZNE-2025-01229 SUP
|
|||||||
| version 1 |
| ||||||